Subscribe to:
• POZ magazine • E-newsletters
POZ Personals Sign In / Join
Username:
 Password:
Back to home » Top Stories » ICAAC 2007

emailrssprint

Coming Down the Pike: Expanding HIV Treatment Options

September 19, 2007

Peter Staley asks Dr. Joe Eron about the latest data from the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) on soon-to-be-approved Isentress and another integrase inhibitor called elvitegravir, and an entry inhibitor you might inject just once every other week.



9 minutes. Click here to view the transcript.

NEW! Scroll down to comment on this story.

emailrssprint


Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Dennis, Albuquerque, 2007-09-20 21:14:46
I sometime have I allergic reactions to FUZEON injections and NIASPAN most of the time it's so bad I have to take DPHENHYDRAME to stop the Hives & the icthy needle stick injection sites, is Pro140 something I should ask my HIV Doctor about? and would I benefit fron taking Pro140? Thanks for your time!

Al, , 2007-09-19 17:53:02
Pro140? I was giving myself injections of Fuzeion and I stopped because, I had allergic reactions to it. Now, Im not taking anything. Will Pro140 give you physical side effects, like the lypo's, and will it work for me since I stopped the Fuzeion. Thanks, Al Oakes, Jr.

comments 1 - 2 (of 2 total)    


[Go to top]


September 20, 2007
Wisdom for Women: An Expert's Take on HIV and Gender Differences
Peter Staley asks Dr. Sharon Walmsley what women need to know about HIV and antivirals, and gender differences needing more research.
September 19, 2007
Coming Down the Pike: Expanding HIV Treatment Options
Peter Staley asks Dr. Joe Eron about the latest data on soon-to-be-approved Isentress and an entry inhibitor you might inject just once every other week.
New Data Explores Current Treatment Options
Peter Staley asks Dr. Joe Eron about the good news on a challenging drug -- newly-approved Selzentry -- and the very potent new protease inhibitor, Prezista.
September 18, 2007
Secrets of a Long-Term Survivor
Peter Staley talks with Matt Sharp about his activism, his new regimen, and his facial lipo fix.
Interview with a Hep C Activist & Survivor
Peter Staley interviews Jules Levin, an activist and survivor of hepatitis C and HIV coinfection, about the latest in HCV treatment and prevention.


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertise/contact us]

© 2008 Smart + Strong. All Rights Reserved. terms of use and your privacy